Related Experiment Video
Updated: Mar 10, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
[Left atrial appendage in rheumatic mitral valve disease: The main source of embolism in atrial fibrillation]
Ovidio A García-Villarreal1, José A Heredia-Delgado1
1Departamento de Cirugía Cardiaca, Hospital de Cardiología UMAE 34, Instituto Mexicano del Seguro Social, , Monterrey, Nuevo León, México.
Insights
Surgical removal of the left atrial appendage in patients with rheumatic mitral valve disease and persistent atrial fibrillation may eliminate stroke risk and the need for anticoagulation. This procedure targets a potential source of emboli, improving patient outcomes.
Area of Science:
- Cardiology
- Cardiac Surgery
- Vascular Surgery
Background:
- Rheumatic mitral valve disease (RMVD) and persistent atrial fibrillation (AF) increase stroke risk.
- The left atrial appendage (LAA) is a potential source of thromboembolism in AF patients.
- Long-term oral anticoagulation is often required but carries bleeding risks.
Purpose of the Study:
- To evaluate the efficacy of LAA resection in reducing stroke incidence in RMVD patients with persistent AF.
- To assess the feasibility of discontinuing oral anticoagulation post-LAA resection.
- To investigate the association between LAA thrombi and embolic events.
Main Methods:
- A prospective observational study of 27 adult patients undergoing mitral valve surgery and LAA resection.
- Oral anticoagulation was ceased 3 months post-surgery.
- Outcomes included absence of embolic stroke and assessment of postoperative LAA embolism via echocardiography.
Main Results:
- No embolic strokes occurred after 3 months post-surgery.
- One transient ischemic attack (TIA) occurred while on warfarin pre-operatively.
- Pre-operative LAA thrombi were identified in 40.7% of patients, with 54.5% of these having a history of embolic stroke.
Conclusions:
- LAA resection may be a primary strategy to prevent stroke in RMVD patients with persistent AF.
- Eliminating the LAA could negate the need for long-term anticoagulation.
- The LAA is a significant source of emboli in this patient population.
Objective:
To demonstrate that surgical removal of the left atrial appendage in patients with rheumatic mitral valve disease and long standing persistent atrial fibrillation decreases the possibility of stroke. This also removes the need for long-term oral anticoagulation after surgery.
Method:
A descriptive, prospective, observational study was conducted on 27 adult patients with rheumatic mitral valve disease and long standing persistent atrial fibrillation, who had undergone mitral valve surgery and surgical removal of the left atrial appendage. Oral anticoagulation was stopped in the third month after surgery. The end-point was the absence of embolic stroke. An assessment was also made of postoperative embolism formation in the left atrium using transthoracic echocardiography.
Results:
None of the patients showed embolic stroke after the third post-operative month. Only one patient exhibited transient ischaemic attack on warfarin therapy within the three postoperative months. Left atrial thrombi were also found in 11 (40.7%) cases during surgery. Of these, 6 (54.5%) had had embolic stroke, with no statistical significance (P=.703).
Conclusions:
This study suggests there might be signs that the left atrial appendage may be the main source of emboli in rheumatic mitral valve disease, and its resection could eliminate the risk of stroke in patients with rheumatic mitral valve disease and long-standing persistent atrial fibrillation.
Related Concept Videos
Mitral Stenosis I: Introduction
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis III: Medical Management
Mitral Regurgitation I: Introduction
Mitral Valve Prolapse I: Introduction

